PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

Reviews on Recent Clinical Trials, published by Bentham Science Publishers Ltd, is a distinguished journal in the medical and pharmacological fields, assessing the latest advancements in clinical research since its inception in 2006. With a focus on integrating multidisciplinary approaches to evaluating clinical trial methodologies, the journal caters to a diverse audience of researchers, professionals, and students keen on enhancing their knowledge and understanding of innovative therapeutic strategies and drug developments. Notably positioned in the Q3 quartile as ranked by Scopus for both 'Medicine (miscellaneous)' and 'Pharmacology', the journal illustrates a growing academic influence, evidenced by its Scopus rankings—holding a commendable 72nd percentile in general medicine and a 33rd percentile in pharmacology. While the journal is not open access, it remains committed to disseminating high-quality, peer-reviewed content that drives forward the conversation in clinical research. For those interested in staying abreast of novel findings and comprehensive reviews within the clinical trial landscape, Reviews on Recent Clinical Trials stands out as an essential resource.

JACC-Heart Failure is a premier journal in the field of cardiology, published by Elsevier Science Ltd, that has rapidly established itself as a vital resource for researchers and practitioners focused on heart failure and cardiovascular health. With an impressive impact factor and ranking in the Q1 category for Cardiology and Cardiovascular Medicine, this journal is recognized for its high-quality peer-reviewed articles that contribute significantly to advancements in clinical practice and scientific understanding of heart failure. As of 2023, the journal ranks #10 out of 387 in its field, positioning it in the 97th percentile of Scopus rankings, which highlights its influential role in disseminating cutting-edge research. Although the journal does not operate under an open-access model, it maintains a rigorous review process, ensuring the publication of articles that are both innovative and clinically relevant. Targeting an audience of dedicated researchers, healthcare professionals, and students, JACC-Heart Failure serves as an essential platform for exploring the complexities of heart failure treatments, management strategies, and future directions in cardiology.

Japan Journal of Nursing Science, published by WILEY, serves as a pivotal resource in the field of nursing, focusing on innovative research and theoretical developments that enhance nursing science practices. With an ISSN of 1742-7932, this journal has established itself as a reputable platform, reflected in its 2023 rankings, which place it in the Q2 category for both Medicine (miscellaneous) and Research and Theory. Covering a broad range of topics crucial to the advancement of nursing, the journal provides researchers, professionals, and students access to high-quality studies, methodologies, and discussions that shape contemporary nursing practices and policies. Though not an Open Access journal, it contributes significantly to the academic discourse and research community, with emphasis on fostering evidence-based practices and promoting excellence in nursing education and healthcare delivery. With a cumulative publishing history from 2006 to the present, the Japan Journal of Nursing Science is committed to disseminating vital knowledge that enriches the nursing profession and improves patient care.

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

Rehabilitation Nursing, published by Lippincott Williams & Wilkins, is an esteemed journal dedicated to advancing the fields of rehabilitation, nursing, and physical therapy. With an ISSN of 0278-4807 and an E-ISSN of 2048-7940, this journal has been a crucial resource for practitioners and researchers since its inception in 1975, continuously providing insights through its convergence of scholarship up to 2024. As a member of the Q3 category in multiple disciplines, including Medicine (Miscellaneous), Nursing (Miscellaneous), and Physical Therapy, the journal affirms its relevance within the academic community, particularly highlighted by its Scopus rankings. With a focus on disseminating innovative research, clinical findings, and evidence-based practices, Rehabilitation Nursing aims to enhance patient care and foster improvements in rehabilitation strategies. Whether one seeks to stay abreast of the latest developments or contribute new insights, this journal is a must-read for those involved in the fields of rehabilitation and nursing.

Statistics in Biopharmaceutical Research, published by Taylor & Francis Inc, is a premier journal that occupies a crucial space in the realms of Pharmaceutical Science and Statistics and Probability. With a robust impact factor affirmed by its Q1 rankings in both categories, the journal stands as a beacon for innovative statistical methodologies and their applications in biopharmaceutical research. Researchers and professionals will find a rich repository of high-quality articles that address contemporary challenges in drug development, clinical trials, and regulatory frameworks. Since its inception in 2011, the journal has continued to foster interdisciplinary collaboration, making significant strides towards enhancing statistical practice in biomedicine. With a commitment to academic rigor and practical relevance, Statistics in Biopharmaceutical Research is an essential resource for anyone looking to advance their understanding and application of statistical techniques in the pharmaceutical industry.

Implementation Science is a premier open-access journal published by BMC that has been at the forefront of advancing the field of implementation research since its inception in 2006. With an impressive reputation, this journal has consistently ranked in the Q1 quartile across various categories including Health Informatics, Health Policy, Medicine, and Public Health, reflecting its significant impact and relevance in shaping policy and practice. The journal's robust metrics, including a Scopus rank of #7 in Health Policy and #15 in Public Health, underline its credibility and the high-quality scholarship it publishes. By providing an open access platform, Implementation Science ensures that vital research findings reach a broad audience, facilitating knowledge translation and improving health outcomes on a global scale. Researchers, practitioners, and students engaged in the fields of health services research, policy implementation, and public health will find this journal to be an invaluable resource in their quest for evidence-based solutions.

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.

Addiction Science & Clinical Practice is a premier open-access journal dedicated to advancing the understanding and treatment of addiction through evidence-based research and clinical practice. Published by BMC in the United Kingdom since 2007, this journal has significantly impacted the fields of Clinical Psychology, Medicine, and Psychiatry and Mental Health, proudly securing a Q1 ranking in multiple categories as of 2023. With an emphasis on high-quality research, the journal provides an inclusive platform for the dissemination of innovative findings and clinical insights that address the complexities of addiction. Researchers, practitioners, and students alike benefit from its unrestricted access since 2012, allowing for widespread dissemination of knowledge. Located at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to lead the way in fostering collaboration and informing best practices in addiction science.